BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Hoya Vision Care Expands Its Direct Presence in Romania

  October 21, 2013

   · 

  1 min read
• Drug Development

  GANYMED Pharmaceuticals AG’s IMAB362 Receives Orphan Drug Designation From FDA and European Medicines Agency for Pancreatic Cancer

  October 21, 2013

   · 

  3 min read
• Pharm Country

  Rockland Immunochemicals Awarded Phase I SBIR Funding to Develop Novel Agents for Cancer Diagnosis and Targeted Therapy

  October 21, 2013

   · 

  3 min read
• Pharm Country

  Integra LifeSciences Corporation Introduces Next-Generation Licox® Brain Tissue Oxygen Monitoring System

  October 21, 2013

   · 

  1 min read
• Drug Development

  OXiGENE Presents Preclinical Data Demonstrating Significant Antitumor Activity of ZYBRESTAT® in Pancreatic Neuroendocrine Tumor Model

  October 21, 2013

   · 

  1 min read
• Pharm Country

  Celsus Therapeutics’ MRX-6 Selected as One of the “Top Autoimmune/Anti-Inflammatory Disease Projects to Watch” by Elsevier Business Intelligence

  October 21, 2013

   · 

  1 min read
• Business

  Cempra, Inc. to Present at the Second Annual Generating Evidence for Reimbursement Decisions: Therapeutics Conference

  October 21, 2013

   · 

  1 min read
• Biotech Bay

  Five Data Presentations on BioMarin Pharmaceutical Inc.'s BMN 673 PARP Inhibitor at the 2013 American Association for Cancer Research-National Cancer Institute-EORTC International Conference on Molecular Targets and Cancer Therapeutics

  October 21, 2013

   · 

  1 min read
• Biotech Bay

  OncoMed Pharmaceuticals, Inc. Updates Phase 1b Data for Demcizumab With Pemetrexed and Carboplatin in Patients With First-Line Stage IIIb/IV Non-Small Cell Lung Cancer at the American Association for Cancer Research-National Cancer Institute-EORTC Interna

  October 21, 2013

   · 

  1 min read
• Drug Development

  Stellar Biotechnologies, Inc. Immunotherapy Technology Demonstrates Protection Against Clostridium Difficile Infection in Preclinical Study

  October 21, 2013

   · 

  4 min read